Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Intellipharmaceutics International Inc V.IPCI.H

Alternate Symbol(s):  IPCIF

Healthcare
Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. It has developed several... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:IPCI.H)

Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan

Accesswire March 13, 2024

Intellipharmaceutics Announces Cease Trade Order

Accesswire March 6, 2024

Canadian Investment Regulatory Organization Trading Halt - IPCI

Canada NewsWire March 6, 2024

Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form

Accesswire February 26, 2024

Intellipharmaceutics International Inc. Announces Stock Option Grant

Accesswire February 8, 2024

Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange

Accesswire January 2, 2024

Intellipharmaceutics Announces Third Quarter 2023 Results

Accesswire October 16, 2023

Intellipharmaceutics Reports Director Election Results

Accesswire September 14, 2023

TSX breakout: Intellipharmaceutics stock rallies

Jonathon Brown August 25, 2023
View More News ››

Opinion & Analysis (TSXV:IPCI.H)

Dialing back euphoria: the Intellipharmaceutics prescription for opioid abuse

The Life Sciences Report May 12, 2016

Canadian Biotech comes back to life: A buyer's guide

Tony Pullen January 21, 2014

Mystery Movers: Biomed shares surging, triple digit rises all over, executives baffled

Chris Parry November 19, 2013
View More Opinion ››

Bullboard Posts (TSXV:IPCI.H)

Comments on Recent Trading Activity

TORONTO, ON / ACCESSWIRE / December 22, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("...
Betteryear2 - December 22, 2021

Sold all my shares !

Good for me: i sold all my shares This company seems having no future. Dead place without news !
whoknows - July 6, 2021

Is IPCI a dying company ???????

Is IPCI a company with a stagnant market value? No news to stimulate the stock market!   Has IPCI become an empty shell...
whoknows - May 5, 2021

ANDA

Dexmethylphenidate ER Metformin ER Venlafaxine ER Pantoprazole ER Quetiapine ER Lamotrigine ER Levetiracetam ER Desvenlafaxine ER...
Normandt1965 - April 25, 2021

RE:Buyer beware!

They've been saying since last November that if they get enough money they'll be launching generic Seroquel XR®...
biggerr - April 25, 2021

Buyer beware!

I just sold my last 52 shares @ $0.28 of IPCI from holdings since the Vasogen days when IPCI took over Vasogen Oct22/2009 and they have...
TrumpThis - April 23, 2021
View more Bullboard ››

Fobi AI Inc

Fobi AI Inc

Fobi AI Inc. is a Canada-based artificial intelligence (AI) and data intelligence company. The Company operates in the ...
View More »